Effects of Recombinant Human Growth Hormone and Sex Hormone on Children with Turner Syndrome
Xiang Cheng-fa
Abstract
Xiang Cheng-fa
Abstract
Objective To explore the therapeutic effects of recombinant human growth hormone(rhGH) and sex hormone on the stature and sex feature of children with Turner syndrome(TS).Methods A total of 22 children with TS were selected in the outpatients department of West China Second Hospital between January 2005 and June 2009.Twelve children with TS the average age of(13.58±2.23) years] received rhGH [0.15 U/(kg·d)] every night before sleep for 4-24 months.Sixteen children with TS(age≥14 years old,bone age≥11 years old) underwent estrogen and progestogen(E/P) treatment for 3-30 months.Results The height and height standard deviation score increased significantly in children with rhGH therapy(P0.01).The height velocity was(9.33±2.39)cm/year after the treatment.The treatment of estrogen and progestogen could promote the development of breast and establish menstrual cycle in children with TS.Conclusion rhGH and E/P can play a significant role in treatment of TS in children.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the therapeutic effects of recombinant human growth hormone(rhGH) and sex hormone on the stature and sex feature of children with Turner syndrome(TS).Methods A total of 22 children with TS were selected in the outpatients department of West China Second Hospital between January 2005 and June 2009.Twelve children with TS the average age of(13.58±2.23) years] received rhGH [0.15 U/(kg·d)] every night before sleep for 4-24 months.Sixteen children with TS(age≥14 years old,bone age≥11 years old) underwent estrogen and progestogen(E/P) treatment for 3-30 months.Results The height and height standard deviation score increased significantly in children with rhGH therapy(P0.01).The height velocity was(9.33±2.39)cm/year after the treatment.The treatment of estrogen and progestogen could promote the development of breast and establish menstrual cycle in children with TS.Conclusion rhGH and E/P can play a significant role in treatment of TS in children.
Key concepts: Medicine, Breast development, Progestogen, Bone age, Short stature, Turner syndrome, Estrogen, Turner's syndrome